Spelling suggestions: "subject:"pharmacy ciences"" "subject:"pharmacy csciences""
81 |
Formulation and Characterization of Thermosensitive Chitosan Hydrogels for Injectable Drug DeliveryHill, Kyle S. January 2020 (has links)
No description available.
|
82 |
Design, Optimization and Evaluation of a Novel Emulgel of Ibuprofen for Enhanced Skin Delivery using Formulating for Efficacy™ softwareChadha, Aastha January 2018 (has links)
No description available.
|
83 |
Development of a Lipid Nanoparticle-based Antisense Delivery Platform for Cancer TherapyCheng, Xinwei January 2018 (has links)
No description available.
|
84 |
DNA Adducts from 5'-Aldehyde Lesions and their Contributions to the Endogenous ExposomeCho, Shin Hae 28 August 2019 (has links)
No description available.
|
85 |
Role of OCTN1 (SLC22A4) in the Disposition of Nucleoside Analogs in AMLAnderson, Jason T., PharmD January 2019 (has links)
No description available.
|
86 |
Solubility Improvement by Solid Dispersion and Their Characterization: Indomethacin and PhenytoinSridhar, Vishak 20 May 2013 (has links)
No description available.
|
87 |
Managing Medication Regimen: Arthritis Patients' PerceptionNugraheni, Gesnita 27 August 2013 (has links)
No description available.
|
88 |
Allosteric Modulation of M1 Muscarinic Receptors by Amiodarone and Related LigandsSlane, Elizabeth Goldie January 2020 (has links)
No description available.
|
89 |
Evaluation of heart failure clinic alternative-clinician effectiveness studyBandy, Veronica Tovar 01 January 2008 (has links) (PDF)
Heart failure in its simplest terms can be defined as the inability of the heart to pump blood in adequate amounts to maintain circulation. A more descriptive definition of HF is a complex clinical syndrome, where the myocardium is unable to pump sufficient amounts of blood to supply the metabolic needs of the body which may be characterized by dyspnea, fatigue, effort intolerance, and decreased survival. Data from the recent heart disease and stroke statistics update from the American Heart Association has startling implications. The overall prevalence of total cardiovascular disease in the United States is 79.4 million individuals. While the prevalence of heart failure only encompasses 2.5% of the overall total, heart failure affects 57.7 thousand Americans. It is interesting to note that the prevalence of heart failure is equally distributed among men and women. In the past, it was thought of a disease that mostly affected men. The cost of treatment of heart failure is staggering. Since 1979 there has been an overall increase in heart failure hospital discharges of 175 percent. In 2007 it is estimated that the total cost of heart failure is $33.2 billion in the United States. Based on these estimates, the Evaluation of Heart Failure Clinic Alternative - Clinician Effectiveness Study was begun at San Joaquin General Hospital.
|
90 |
Analysis of soy natural products and esterase enzymes for drug developmentJurkiewicz, Crystal A. 24 August 2011 (has links)
No description available.
|
Page generated in 0.0641 seconds